49198
Anhui Huaheng Biotechnology Co.,Ltd
Nov 20, 2024
China
East Asia and the Pacific
Dec 20, 2024
B - Limited
Pending Approval
Nov 20, 2024
Regional Industry - MAS Asia & Pac
Agribusiness and Forestry
Other Food
Anhui Huaheng Biotechnology Co., Ltd. (AHB or the Company) is a leading manufacturer of amino acids and other bio-based products in the People’s Republic of China (PRC). IFC is proposing to provide up to RMB 500 million (equivalent to US$70.5 million) in the form of a Green Loan (the Loan) to Qinhuangdao Huaheng Bioengineering Co., Ltd. (QHB), a wholly-owned subsidiary of AHB. The IFC proceeds will be used to fund the capex and working capital needs of malic acid and L-Tryptophan production (the Project).
IFC will provide support to AHB on its near-term expansion outside of China, to bring the technology and affordable nutrition manufacturing capability to wider emerging markets. Under current Upstream and Advisory program to systematically address South-South activities in Asia, IFC will invite AHB to thematic seminars and workshops that share knowledge and experiences of Chinese manufacturers conducting outbound investments, as the Company moves forward with implementation.
For Inquiries About the Project, Contact
For Inquiries and Comments About IFC, Contact
Local Access of Project Documentation
18 Shenshan Road, Shan Haiguan District, Qinhuangdao, Hebei Province, PRC